Care recommendations for patients with cancer and hematological neoplasms amid the COVID-19 pandemic in Colombia
DOI:
https://doi.org/10.35509/01239015.701Keywords:
COVID-19, Oncology, Hematology, Care, PandemicAbstract
IIn response to the Covid-19 pandemic, declared in March 2020 by the World Health Organization (WHO), the Colombian Association of Hematology and Oncology (ACHO) has been issuing communications aimed at providing guidance to health professionals involved in the treatment of hematological and oncological patients.
Considering the pandemic mitigation phase we are currently facing, and the government’s approach to progressively tapering-off the quarantine, we deem it important to release a new update.
These recommendations are not intended to impose a single conduct, since we understand that each case has particular characteristics and therefore it must be acted upon by individualizing each specific situation. The recommendations are based on documents issued by well-known cancer and hematological scientific associations, and are subject to change as more information becomes available.
Author Biographies
Aylen Vanessa Ospina-Serrano, ICCAL Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D. C., Colombia
Virginia abello-Polo, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Orlando Bonell Patino-Escobar, Department of Laboratory Medicine. University of California San Francisco (UCSF), San Francisco, USA
Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Javier Ignacio Godoy-Barbosa, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Servicio de Oncología, Clínica de Marly, Bogotá, D. C., Colombia
Jaime Gonzalez, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Servicio de Hemato-Oncología, Oncólogos del Occidente SAS, Armenia, Colombia
Henry Idrobo, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Diego Emilio Lopera-Cortés, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Servicio de Hemato-Oncología, Oncólogos del Occidente SAS, Armenia, Colombia
Humberto Martinez-Cordero, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Unidad de Hematología y Trasplante de Médula Ósea, Instituto Nacional de Cancerología E.S.E., Bogotá, D. C., Colombia
Mario Fernando Quintero-Ocaris, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Servicio de Hematología, E.S.E Hospital Universitario Erasmo Meoz, Cúcuta, Colombia
Servicio de Hematología, Clínica de Cancerología de Norte de Santander, Cúcuta, Colombia
Javier Segovia-Gomez, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Servicio de Hematología y Oncología, Hospital Militar Central, Bogotá, D. C., Colombia
Carlos Alberto Vargas-Baez, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
Servicio de Oncología, Clínica del Country, Bogotá, D. C., Colombia
Fundación para la Investigación Clínica y Molecular Aplicada al Cáncer (FICMAC), Bogotá, D. C., Colombia
Andres Yepes, Junta directiva, Asociación Colombiana de Hematología y Oncología (ACHO), Bogotá, D. C., Colombia
References
Salud INd. Coronavirus (COVID-19) en Colombia https://www.ins.gov.co/Noticias/Paginas/Coronavirus.aspx: Instituto Nacional de Salud; 2020.
Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21(3):335-7. https://doi.org/10.1016/S1470-2045(20)30096-6
Zhang L, Zhu F, Xie L, Wang C, Wang J, Chen R, et al. Clinical characteristics of COVID-19-infected cancer patients: a retrospective case study in three hospitals within Wuhan, China. Ann Oncol. 2020;31(7):894-901. https://doi.org/10.1016/j.annonc.2020.03.296
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020;395(10223):497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
ASCO. ASCO Special Report: A guide to cancer care delivery during the COVID-19 PANDEMIC. May 19, 20202020.
ESMO. ESMO Recommendiations: Cancer patient managment during COVID-19 pandemic. General Introduction. Slides sets [Internet]. 2020.
SEOM. Posicionamiento-Recomendaciones SEOM sobre el cribado serológico previo al inicio de una quimioterapia inmunosupresora durante la pandemia COVID19. Pacientes asintomáticos sin infección conocida. https://seom.org/images/Posicionamiento_TESTS_COVID_QUIMIO.pdf: SEOM 2020.
Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, et al. Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study. Lancet. 2020;395(10241):1907-18. https://doi.org/10.1016/S0140-6736(20)31187-99. AMA. AMA quick guide to telemedicine in practice: https://www.ama-assn.org/practice-management/digital/ama-quickguide-telemedicine-practice; 2020.
Saavedra C. Consenso Colombiano de atención, diagnóstico y manejo de infección por SAR-COV-2/COVID-19 en establecimientos de atención de la salud. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3). https://doi.org/10.22354/in.v24i3.852
Ueda M, Martins R, Hendrie PC, McDonnell T, Crews JR, Wong TL, et al. Managing Cancer Care During the COVID-19 Pandemic: Agility and Collaboration Toward a Common Goal. J Natl Compr Canc Netw. 2020:1-4. https://doi.org/10.6004/jnccn.2020.7560
Hunter E, Price DA, Murphy E, van der Loeff IS, Baker KF, Lendrem D, et al. First experience of COVID-19 screening of health-care workers in England. Lancet. 2020;395(10234):e77-e8. https://doi.org/10.1016/S0140-6736(20)30970-3
Quattrone F, Vabanesi M, Borghini A, De Vito G, Emdin M, Passino C. The value of hospital personnel serological screening in an integrated COVID-19 infection prevention and control strategy. Infect Control Hosp Epidemiol. 2020:1-2. https://doi.org/10.1017/ice.2020.242
Hanna TP, Evans GA, Booth CM. Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic. Nat Rev Clin Oncol. 2020;17(5):268-70. https://doi.org/10.1038/s41571-020-0362-6
ASCO SPECIAL REPORT: A GUIDE TO CANCER CARE DELIVERY DURING THE COVID-19 PANDEMIC. MAY 19, 2020.
ESMO Recommendiations: Cancer patient managment duringCOVID-19 pandemic. General Introduction. Slides sets [Internet]. 2020.
Wang Y, Zhang S, Wei L, Lin Z, Wang X, Wang J, et al.Recommendations on management of gynecological malignancies during the COVID-19 pandemic: perspectives from Chinese gynecological oncologists. J Gynecol Oncol. 2020;31(4):e68. https://doi.org/10.3802/jgo.2020.31.e68
Kimberly H, Angela C, Arias C, Englund J, Lee M. Infectious Diseases Society of America G8uidelines on the Diagnosis of COVID-192020.
Solodky ML, Galvez C, Russias B, Detourbet P, N’Guyen-Bonin V, Herr AL, et al. Lower detection rates of SARS-COV2 antibodies in cancer patients versus health care workers after symptomatic COVID-19. Ann Oncol. 2020; 31(8):1087-8. https://doi.org/10.1016/j.annonc.2020.04.475
Saavedra C. Adendo: Actualización Consenso 27/06/2020. Consenso Colombiano de atención, diagnóstico y manejo de la infección por SARS-CoV-2/COVID-19 en establecimientos de atención de la salud. Segunda edición. Recomendaciones basadas en consenso de expertos e informadas en la evidencia. Infectio. 2020;24(3). https://doi.org/10.22354/in.v24i3.895
AEC, editor. Qué debemos saber los cirujanos en los casos de patología oncológica en el contexto de la pandemia por covid-19 (SARS-CoV-2)? recomendaciones del grupo “Cirugia AEC-COVID19” de la Asociación española de cirujanos (AEC), versión actualizada 30 marzo2020. Disponible en: https://www.aecirujanos.es/files/noticias/152/documentos/dossier_v_1_10.pdf:Asociación Española de Cirujanos; 2020.
AEC. Recomendaciones de actuación en cirugía oncológica del área hepatobiliopancreática durante la pandemia COVID-192020.
AEC. Recomendaciones de actuación en cirugía oncológica esófago-gástricas durante la pandemia COVID-19 (V3, 2-42020)2020.
Younes N, Al-Sadeq DW, Al-Jighefee H, Younes S, Al-Jamal O, Daas HI, et al. Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2. Viruses. 2020;12(6):582. https://doi.org/10.3390/v12060582
Di Saverio S, Pata F, Gallo G, Carrano F, Scorza A, Sileri P, et al. Coronavirus pandemic and colorectal surgery: practical advice based on the Italian experience. Colorectal Dis. 2020;22(6):62534. https://doi.org/10.1111/codi.15056
The Royal College of Surgeons of England. COVID-19: Good Practice for Surgeons and Surgical Teams [internet]; 2020. Disponible en: https://www.rcseng.ac.uk/standards-and-research/standardsand-guidance/good-practice-guides/coronavirus/covid-19-goodpractice-for-surgeons-and-surgical-teams/
Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020;395(10223):507-13. https://doi.org/10.1016/S01406736(20)30211-7
von Lilienfeld-Toal M, Vehreschild JJ, Cornely O, Pagano L, Compagno F, Hirsch HH, et al. Frequently asked questions regarding SARS-CoV-2 in cancer patients-recommendations for clinicians caring for patients with malignant diseases. Leukemia. 2020;34(6):1487-94. https://doi.org/10.1038/s41375-020-0832-y
EBMT. Coronavirus Disease EBMT Recommendations.2020; VERSION 8 - MAY 18, 2020.
Willan J, King A, Hayes S, Collins G, Peniket A. Care of haematology patients in a COVID-19 epidemic. Br J Hematol. 2020; 189(2):241-3. https://doi.org/10.1111/bjh.16620
Indini A, Aschele C, Cavanna L, Clerico M, Daniele B, Fiorentini G, et al. Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian survey. Eur J Cancer. 2020;132:17-23. https://doi.org/10.1016/j.ejca.2020.03.024
Gavillet M, Carr Klappert J, Spertini O, Blum S. Acute leukemia in the time of COVID-19. Leuk Res. 2020;92:106353. https://doi.org/10.1016/j.leukres.2020.106353
SEEH. Actuación frente a COVID-19 en Receptores de Trasplante de Progenitores Hematopoyéticos y pacientes Oncohematológicos. Versión 5. Abril 22 20202020.
ASH. COVID-19 and Acute Myeloid Leukemia: Frequently Asked Questions; 2020.
GELTAMO. Recomendaciones del Comité Científico del grupo GELTAMO para el manejo de los pacientes con linfoma durante la crisis del Covid-19 [internet]. Versión 1 (19 marzo 2020). Disponible en: https://www.sehh.es/covid-19/recomendaciones/123783-recomendaciones-del-comitecientifico-del-grupo-geltamo-para-el-manejo-de-los-pacientescon-linfoma-durante-la-crisis-del-covid-192020.
Martinez-Codero H, Martínez LM, Ospina JA, Ruiz Argüelles G, Abello Polo V. Consenso del Grupo Latinoamericano de estudio de Mieloma Múltiple (MM) GELAMM para el manejo del MM en estado de Pandemia SARS CoV-2 / COVID 19 Recomendaciones Basadas en Consenso de Expertos. Rev Colomb Cancerol. 2020;22(24).
Ospina JA, Martínez-Cordero H, Idrobo QH. CONSENSO Grupo de Estudio Latinoamericano de Linfoproliferativos (GELL) para el manejo del linfoma en estado de pandemia SARS CoV-2 / COVID 19. Rev Colomb Cancerol. 2020;22(24).
ASH. COVID-19 and Indolent Lymphomas: Frequently Asked Questions; 2020.
ASTCT. Interim Guidelines for COVID-19 management in Hematopoietic Cell Transplantation and Cellular Therapy Patients [internet]. Version 1.3. April 16, 2020. Disponible en: https://higherlogicdownload.s3.amazonaws.com/ASBMT/a1e2ac9a-36d2-4e23-945c-45118b667268/UploadedImages/COVID-19_Interim_Patient_Guidelines_4_20_20.pdf2020.
How to Cite
Downloads
Downloads
Published
Issue
Section
License
Todos los derechos reservados.
Article metrics | |
---|---|
Abstract views | |
Galley vies | |
PDF Views | |
HTML views | |
Other views |